Flora Growth (Nasdaq:FLGC) - Aandelenkoers, Nieuws & Analyse

FLGC Overzicht aandelen

Flora Growth Corp. houdt zich, samen met haar dochterondernemingen, wereldwijd bezig met de groei, teelt en ontwikkeling van medicinale cannabis en daarvan afgeleide producten. Meer informatie

FLGC fundamentele analyse
Sneeuwvlok Score
Waardering	3/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	3/6
Dividenden	0/6

Beloningen

Handelen tegen een goede waarde vergeleken met branchegenoten en branchegenoten

Risicoanalyse

Zeer volatiele aandelenkoers in de afgelopen 3 maanden

Aandeelhouders zijn het afgelopen jaar substantieel verwaterd

Heeft minder dan 1 jaar cash runway

Heeft geen betekenisvolle marktkapitalisatie ( $17M )

+ 1 meer risico

Flora Growth Corp. Concurrenten

AXIL Brands

NYSEAM:AXIL

US$25.9m

Upexi

NasdaqCM:UPXI

US$5.4m

LFTD Partners

OTCPK:LIFD

US$8.3m

DSwiss

OTCPK:DQWS

US$15.1m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Flora Growth
Historische aandelenkoersen
Huidige aandelenkoers	US$1.43
52 Week Hoogtepunt	US$2.93
52 Week Laag	US$0.75
Bèta	1.86
11 maand verandering	-15.88%
3 maanden verandering	38.16%
1 Jaar Verandering	74.82%
33 jaar verandering	-96.37%
5 jaar verandering	n/a
Verandering sinds IPO	-98.51%

Recent nieuws en updates

Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?

Nov 20

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Sep 18

Recent updates

Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?

Nov 20

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Sep 18

Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts

Aug 16

Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch

May 22

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Apr 04

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

Feb 17

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Dec 22

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Apr 17

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Dec 08

Flora Growth gains on deal to acquire No Cap Hemp assets

Sep 07

Elshad Garayev is the new finance chief of Flora Growth

Jul 11

Rendement voor aandeelhouders

	FLGC	US Personal Products	US Markt
7D	22.2%	1.4%	0.3%
1Y	74.8%	-12.5%	31.1%

Rendement versus industrie: FLGC overtrof de US Personal Products industrie, die het afgelopen jaar een rendement -12.5 % opleverde.

Rendement versus markt: FLGC overtrof de US markt, die het afgelopen jaar een rendement opleverde van 31.1 %.

Prijsvolatiliteit

Is FLGC's price volatile compared to industry and market?
FLGC volatility
FLGC Average Weekly Movement	18.9%
Personal Products Industry Average Movement	8.4%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

Stabiele aandelenkoers: De aandelenkoers van FLGC is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 19% ) van FLGC is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen US.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2019	103	Clifford Starke	www.floragrowth.com

Flora Growth Corp. houdt zich, samen met haar dochterondernemingen, wereldwijd bezig met de groei, teelt en ontwikkeling van medicinale cannabis en daarvan afgeleide producten. Het bedrijf is actief in drie segmenten: House of Brands, Commercial and Wholesale, en Pharmaceuticals. Het bedrijf kweekt, verwerkt en levert cannabisbloemen van medicinale kwaliteit en van cannabis afgeleide medische en welzijnsproducten.

Flora Growth Corp. Samenvatting

Hoe verhouden de winst en inkomsten van Flora Growth zich tot de beurswaarde?
FLGC fundamentele statistieken
Marktkapitalisatie	US$17.49m
Inkomsten(TTM)	-US$18.00m
Inkomsten(TTM)	US$64.15m

0.3x

P/S-verhouding

-1.1x

Koers/Winstverhouding

Is FLGC overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
FLGC resultatenrekening (TTM)
Inkomsten	US$64.15m
Kosten van inkomsten	US$50.80m
Brutowinst	US$13.35m
Overige uitgaven	US$31.35m
Inkomsten	-US$18.00m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-1.35
Brutomarge	20.81%
Nettowinstmarge	-28.05%
Schuld/Eigen Vermogen Verhouding	43.1%

Hoe presteerde FLGC op de lange termijn?

Bekijk historische prestaties en vergelijking

FLGC Overzicht aandelen

Beloningen

Risicoanalyse

Flora Growth Corp. Concurrenten

NYSEAM:AXIL

US$25.9m

NasdaqCM:UPXI

US$5.4m

OTCPK:LIFD

US$8.3m

OTCPK:DQWS

US$15.1m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?

New major risk - Revenue and earnings growth

New major risk - Financial position

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Flora Growth Corp. Appoints Manfred Ziegler as Managing Director

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Recent updates

Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?

New major risk - Revenue and earnings growth

New major risk - Financial position

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Flora Growth Corp. Appoints Manfred Ziegler as Managing Director

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Flora Growth Corp. Announces Board Changes

Flora Growth Announces Update on Compliance with the Audit Committee Composition Requirements of Nasdaq Listing Rule 5605(c)(2)(A)

Consensus revenue estimates fall by 12%

Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp. (NasdaqCM:FLGC) acquired Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV:LFST) for CAD 0.87 million.

Flora Growth Corp., Annual General Meeting, Aug 14, 2024

High number of new and inexperienced directors

Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch

Consensus EPS estimates upgraded to US$0.41 loss, revenue downgraded

Forecast to breakeven in 2025

First quarter 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Shareholder dilution

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Flora Growth Corp. has completed a Follow-on Equity Offering in the amount of $3.23 million.

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

New major risk - Market cap size

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Flora Growth Corp. Receives Non-Compliance Notice From NASDAQ

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Revenue and earnings growth

Flora Growth Corp. Announces the Resignation of Juan Carlos Roa Gomez as Director

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. (NasdaqCM : FLGC) entered into a Sale and Purchase Agreement to acquire Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV : LFST) for $1.9 million.

Second quarter 2023 earnings: Revenues miss analyst expectations

Flora Growth Corp. Announces Resignation of Matthew Cohen as General Counsel

Flora Growth Corp. Appoints Dany Vaiman as Chief Financial Officer

Flora Growth Regains Compliance with Nasdaq Minimum Bid Requirement

Consensus EPS estimates upgraded to US$0.03 loss

Flora Growth Corp. Announces Board Appointments

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates upgraded to US$0.21 loss

Price target decreased by 24% to US$1.33

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Price target increased by 18% to US$2.92

Flora Growth Corp Provides Revenue Guidance for the Year 2023

Flora Growth Corp. Announces Executive Changes

Price target decreased to US$2.12

Forecast to breakeven in 2024

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Independent Director notifies of intention to sell stock

Third quarter 2022 earnings: EPS misses analyst expectations

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Price target decreased to US$2.67

High number of new and inexperienced directors

Flora Growth Corp. (NasdaqCM:FLGC) entered into a definitive agreement to acquire Franchise Global Health Inc. (TSXV:FGH) for CAD 32.2 million.

No longer forecast to breakeven

Flora Growth gains on deal to acquire No Cap Hemp assets

First half 2022 earnings released: US$0.42 loss per share (vs US$0.13 loss in 1H 2021)